Global Single Cell Multiomics Market to Reach USD 16.6 Billion by 2033, Supported by the Increasing Prevalence of Communicable diseases

December 20, 2024 | Healthcare

According to the latest report by IMARC Group, titled "Single Cell Multiomics Market Report by Type (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics), Product Type (Consumables, Instruments, Software), Technique (Single-Cell Isolation and Dispensing, Single-Cell Analysis), Application (Oncology, Cell Biology, Neurology, and Others), End User (Academic Institutes, Contract Research Organizations, Pharmaceutical and Biotech Companies), and Region 2025-2033," the global single cell multiomics market reached a value of USD 4.6 Billion in 2024. Single cell multiomics refers to an advanced analytical technology that examines and isolates multiple types of molecules from similar individual cells. This, in turn, assists in gaining extensive biological insight regarding cellular properties and architecture of heterogeneous tissues. Apart from this, single cell multiomics aids in analyzing the genome, epigenome, metabolome lineages, transcriptome, and proteome, which are further utilized in cell biology, oncology, immunotherapy, and neurological applications. It relies on isolation and dispensing methodologies for providing images of various molecular layers and complex biological structures. As compared to conventional live-cell fluorescence imaging techniques, single cell multiomics does not destroy cells for assessment purposes and measures multiple types of molecules from a single cell. On account of these properties, it is widely used in hospitals, biotech companies and pharmaceutical organizations.

Global Single Cell Multiomics Market Trends:

The global single cell multiomics market is primarily driven by the increasing prevalence of various lifestyle and communicable diseases, especially amongst the geriatric population. This, in turn, has facilitated the widespread adoption of single cell multiomics across pharmaceutical companies, academic institutions and hospitals for antibody discovery purposes and gaining a high-resolution landscape of cellular components present in the tumor. Additionally, rapid expansion in the healthcare sector and the rising need for personalized medicine and solutions for screening and diagnosing genetic disorders and cell heterogeneity in the micro-environment is acting as another growth-inducing factor. In line with this, significant technological advancements, such as the introduction of barcoding and single-cell multimodal omics (scMulti-omics) solutions, are contributing to the market growth. These systems help in measuring multiple resolutions from similar cells, including chromatin accessibility, messenger ribonucleic acid (mRNA) and deoxyribonucleic acid (DNA). Other factors, such as strategic collaborations amongst key players and continuous investments in the research and development (R&D) activities in the field of medical sciences to introduce single-cell analysis products, are creating a positive outlook for the market. On account of the aforementioned factors, the market is anticipated to reach a value of USD 16.6 Billion by 2033, growing at a CAGR of 14.6% during 2025-2033.

Market Summary:

  • Based on the type, the market has been classified into single cell genomics, proteomics, transcriptomics, and metabolomics.
  • On the basis of the product type, the market has been segmented into consumables, instruments, and software.
  • Based on the technique, the market has been bifurcated into single-cell isolation and dispensing, and single-cell analysis.
  • On the basis of the application, the market has been classified into oncology, cell biology, neurology, and others.
  • Based on the end user, the market has been segmented into academic Institutes, contract research organizations, and pharmaceuticals and biotech companies.
  • On a regional basis, the market has been segregated into North America (United States, and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the industry has also been examined, along with the profiles of the key players being 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings) and Thermo Fisher Scientific Inc.


Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Type, Product Type, Technique, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings) and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Single Cell Multiomics Market to Reach USD 16.6 Billion by 2033, Supported by the Increasing Prevalence of Communicable diseases
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials